Results 271 to 280 of about 118,295 (302)
Some of the next articles are maybe not open access.
[Interferon-gamma release assay on suspicion of active tuberculosis?].
Ugeskrift for laeger, 2009The purpose of this retrospective study was to outline the practical use and clinical value of the immunodiagnostic interferon-gamma release assay (IGRA) on suspicion of active Mycobacterium tuberculosis (TB) infection.A retrospective study of all patients (n=91) tested with IGRA (Quantiferon-TB-Gold, Celletis International, Australia) for M ...
Andrea, Browatzki +1 more
openaire +1 more source
The CRISPR–Cas toolbox for analytical and diagnostic assay development
Chemical Society Reviews, 2021Wei Feng, Qianfan Yang, Feng Li
exaly
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Nature Reviews Clinical Oncology, 2021Mary Beth Beasley +2 more
exaly
Interferon-gamma Release Assays - Erwiderung
DMW - Deutsche Medizinische Wochenschrift, 2007M Löbermann, E. C Reisinger, W Frank
openaire +1 more source
A serological assay to detect SARS-CoV-2 seroconversion in humans
Nature Medicine, 2020Fatima Amanat +2 more
exaly
Nanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs
Nature Nanotechnology, 2022Marta Broto +2 more
exaly
Development of a clinical polygenic risk score assay and reporting workflow
Nature Medicine, 2022Peter Kraft, ScD +2 more
exaly

